domingo, 30 de octubre de 2022

Learning and confirming in publicly funded antiviral trials - The Lancet Infectious Diseases

Learning and confirming in publicly funded antiviral trials - The Lancet Infectious Diseases

No hay comentarios:

Publicar un comentario